Expanding Medicare and Medicaid coverage for advanced cancer diagnostic testing.
This Act expands health coverage under Medicare, Medicaid, and CHIP to include advanced cancer diagnostic and laboratory tests, such as DNA and RNA sequencing. This means individuals diagnosed with cancer will gain easier access to modern molecular diagnostics, which is crucial for planning more effective treatment. Additionally, the law eliminates the deductible requirement in Medicare for these specific tests, reducing out-of-pocket costs for patients.
Key points
Medicare and Medicaid must cover advanced cancer diagnostic tests (e.g., DNA/RNA sequencing) for individuals diagnosed with cancer.
The Medicare deductible is eliminated for these specific tests, lowering direct costs for beneficiaries.
Tests are covered upon diagnosis, recurrence, and as necessary for treatment planning or monitoring disease progression.
Establishes an education program for physicians and the public on genomic testing and its role in cancer diagnosis.
Expired
Citizen Poll